CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$233.66
-2.14 (-0.91%)
▼
5d:
-1.63%
30d:
+8.03%
90d:
+8.42%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Smart Money Accumulation
None View Scanner →
Strength: 5.2/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CAH shows positive signals but monitor for confirmation. Market pricing in 1.1% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CAH shows positive signals but monitor for confirmation. Market pricing in 1.1% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$327.62
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$203.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $233.66, which is considered slightly high relative to its 30-day fair value range of $216.31 to $238.57. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (18.8). At these levels, the market is pricing in 1.1% annual earnings growth.
Technical Outlook: Technically, CAH is showing sideways momentum. The price is currently testing key support at $231.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CAH is showing sideways momentum. The price is currently testing key support at $231.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$216.31 -
$238.57
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($249.60)
- BULLISH: Expecting earnings turnaround to 1.1% growth with 11.0% revenue growth
Trading Range Analysis
30-Day Trading Range
$216.31 -
$238.57
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$231.83
Resistance Level
$243.21
Current Trend
Sideways
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.44
Wall Street Target
$249.60
(+6.8%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-19.5%
Profit Margin
0.6%
Valuation Premium vs History
+1.1% premium
PE vs Historical
19.4 vs 18.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.1%
(market-implied from PE analysis)
1-Year Target
$236.23
(+1%)
2-Year Target
$238.83
(+2%)
3-Year Target
$241.46
(+3%)
3-Yr Target (if PE normalizes)
(PE: 19→19)
PE COMPRESSION
$233.45
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.5%)
$363.03
(+55%)
Base:
(SPY PE: 19.4, Growth: 11.5%)
$324.10
(+39%)
Bear:
(PE: 16.5, Growth: 11.5%)
$275.48
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 35.95 | Current EPS (TTM): $6.56
Bull Case
$475.14
(+103%)
Analyst growth 83.2%, PE expands to 39.5
Base Case
$431.95
(+85%)
Market implied 83.2%, PE stable at 36.0
Bear Case
$160.34
(-31%)
Severe decline -20.0%, PE contracts to 30.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 8:22 PM ET
Data refreshes hourly during market hours. Next update: 9:22 PM
Data refreshes hourly during market hours. Next update: 9:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-05
Ro Khanna
SELL
2026-01-23
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$942 | 64 BUY |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$354 | 65 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$89 | 63 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
